Cardioprotective effects of the estrogen receptors modulators in the conditions of experimental acute myocardial infarction
DOI:
https://doi.org/10.14739/2310-1210.2017.6.114689Keywords:
hypoxia, cardiomyocytes, selective estrogen receptors modulator, cytoprotection, ST2Abstract
According to modern ideas, in myocardial infarction a cascade of pathobiochemical reactions is triggered directly in the ischemic focus, leading to a disturbance in the metabolism of cardiomyocytes, the launch of "parasitral" energy-producing reactions, the development of mitochondrial dysfunction, the complete blockade of the macroergic compounds synthesis, and as a result, cells death. In this regard, in the acute period of myocardial infarction it is pathogenetically justified to use drugs that can affect cardiomyocytes metabolism and restore the course of bioenergetic reactions in the cell.
Aim of study – to evaluate the SERM cardioprotective effects in the conditions of acute myocardial infarction modelling with the use of the ST2 marker.
Materials and methods: The experimental part of the work was performed on 120 mature rats - males weighing 190–230 grams. Small-focal acute myocardial infarction was modelled by the administration of coronary artery spasm induced agents – pituitrin and β1, 2, 3 isoprenaline adrenomimetic for 3 days. The investigated drugs tamoxifen citrate (0.1 mg/kg) (reg. № EF3300), toremifene (0.1 mg/kg) (reg. № 1705834), and also comparators – tiotriazoline (50 mg/kg) (UA/2931/01/02) and capicor (6 Mg/kg) (reg. № 11114) were injected intraperitoneally 20 minutes after the injection of isadrin for 3 days in the above stated doses. The myocardial infarction development was confirmed by electrocardiographic study, as well as the appearance of troponin I in blood plasma. The directivity and severity of pathobiochemical processes in the cardiac tissue, as well as the effect of the studied drugs on them, were studied through the enzyme-linked immunosorbent assay of nitrotirozine and homocysteine concentration in the heart homogenate and ST2 in blood plasma.
Results: Systematic administration of a coronary artery spasm induced agents to laboratory animals led to a gradual, progressive ischemic lesion of cardiomyocytes. Biological markers of myocardial infarction Troponin, ST2 I were registered on the 3rd day after the administration of pituitrin and isadrin in the blood plasma of the control group.
Using selective receptors modulators and reference preparations (thiotriazoline, capicor) in experimental therapy of rats with experimental myocardial infarction promoted the normalization of biochemical processes in cardiomyocytes. However, the effect of the studied drugs was unidirectional with various degree of intensity. All the drugs statistically significantly reduced oxidative stress marker products. The most marked effects were displayed by the selective estrogen receptors modulators toremifene and tamoxifen, which decreased in ST2 blood plasma level (by more than 46 %) providing realization of IL 33 cardioprotective properties. In addition, SERM can limit oxidative and nitrosyl stresses development, leading to a decrease in the concentration of homocysteine and nitrotirozine in the heart. Interaction of these effects of tamoxifen citrate in conditions of acute myocardial infarction modelling resulted in a marked cardioprotective effect, increasing the percentage of animals which survived to an average of 75 %.
Conclusions. The cardioprotective effects of selective estrogen receptor modulators identified by us are an experimental foundation for the relevance and viability of further research in this direction.
References
Kovalenko, V. M., Sirenko, Yu. M., & Dorohoi, A. P. (2013) Khvoroby systemy krovoobihu u strukturi smertnosti naselennia Ukrainy: mify i realnist [Diseases of the circulatory system in the structure of mortality in Ukraine: myths and reality]. Proceedings of the XIV National Congress of Cardiologists of Ukraine. [in Ukrainian].
Mokhort, M. A., & Kutovyi, Yu. M. (2014) Prekondytsiiuvannia miokarda (ohliad literatury) [Myocardial preconditioning (literature review)]. Zhurnal NAMN Ukrainy, 20(2), 160–171. [in Ukrainian].
Belenichev, I. F., Chernij, V. I., Pavlov, S. V., et al. (2015) Nejroprotekciya i nejroplastichnost´ [Neuroprotection and neuroplasticity]. Kyiv: Logos [in Ukrainian].
Belenichev, I. F., Odnokoz, O. V., Pavlov, S. V., Belenicheva, O. I., & Polyakova, E. N. (2012) The Neuroprotective Activity of Tamoxifen and Tibolone during Glutathione Depletion in vitro. Neurochemical Journal, 6(3), 202–212. doi: 10.1134/s181971241203004X.
Pavlov, S., & Belenichev, I. (2014) Molecular and Biochemical Aspects of the Neuroprotective Effect of the Selective Estrogen Receptor Modulator Tamoxifen in a Model of Acute Cerebral Ischemia. Neurochemical Journal, 8(1), 28–32. doi: 10.1134/s1819712413040077.
Pavlov, S. V., & Levchenko, K. V. (2016) Vplyv estroheniv ta selektyvnykh moduliatoriv estrohenovykh retseptoriv na sertsevo-sudynnu systemu [Effect of estrogen and selective estrogen receptor modulators on the cardiovascular system]. Visnyk problem biolohii ta medytsyni, 3(2), 40–44 [in Ukrainian].
Brann, D. W., Dhandapani, K., Wakade, C., Mahesh, V. B., & Khan, M. M. (2007) Neurotrophic and neuroprotective effects of estrogen: Basic mechanisms and clinical implications. Steroids, 72(5), 381–405. doi: 10.1016/j.steroids.2007.02.003.
Enmark, E., & Gustafsson, J. A. (1999) Oestrogen receptors – an overvieu. J. Int. Med., 246(2), 133–8. doi: 10.1046/j.1365-2796.1999.00545.x.
Kim, H. P. (1999) Non-genomic stimulation of estrogen receptors localised in caveolae. Biochem., Biophys. Res. Commun, 263, 257–262.
Pavlov, S.V., & Levchenko, K. V. (2016) Antyoksydantni ta kardioprotektyvni vlastyvosti tamoksyfenu tsytratu za umov hipoksychnoho poshkodzhennia kardiomiotsytiv [Antioxidant and cardioprotective properties of the tamoxifen citrate in cardiomyocytes hypoxic damage]. Farmakolohiia ta likarska toksykolohiia, 51(6), 66–72. [in Ukrainian].
Mehta, S. H., Dhandapani, K. M., De Sevilla, L. M., Webb, R. C., Mahesh, V. B., & Brann, D. W. (2003) Tamoxifen, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized female rat. Neuroendocrinology, 77, 44–50. doi: 68332.
Barbarash, O., Gruzdeva, O., Uchasova, E., Dyleva, Y., Belik, E., Akbasheva, O. et al. (2016) Prognostic Value of Soluble ST2 During Hospitalization for ST-Segment Elevation Myocardial Infarction. Clinical Chemistry, 36, 313–319. doi: 10.3343/alm.2016.36.4.313.
Willems, S., Sels, J. W., Flier, S., Versteeg, D., Buhre, W. F., de Kleijn, D. P., et al. (2013) Temporal changes of soluble ST2 after cardiovascular interventions. European Journal of Clinical Investigation, 43(2), 113–20. doi: 10.1111/eci.12022.
Skali, H., Gerwien, R., Meyer, T. E., Snider, J. V., Solomon, S. D., & Stolen, C. M. (2016) Soluble ST2 and Risk of Arrhythmias, Heart Failure, or Death in Patients with Mildly Symptomatic Heart Failure: Results from MADIT-CRT. J. of Cardiovasc. Trans. Res, 9(5–6), 421–428. doi: 10.1007/s12265-016-9713-1.
Hodakovskyi, O. A., Pavlov, S. V., & Buhtiiarova, N. V. (2013) Vplyv ademolu na pokaznyky obminu NO v shchuriv iz modelliu infarktu miokarda [Ademol effect on NO exchange rates in rats with the model of myocardial infarction]. Ukrainskyi biokhimichnyi zhurnal, 85(3), 85–89. [in Ukrainian].
Lapach, S. N., Chubenko, A. V., & Babich, P. N. (2002) Statisticheskie metody v mediko-biologicheskikh issledovaniyakh s ispol´zovaniem EXCEL [Statistical methods in biomedical research using EXCEL]. Kyiv: MORION. [in Russian].
Pavlov, S. V. (2011) Mitoprotektyvna diia tiolnykh antyoksydantiv v umovakh modeliuvannia nitrozuiuchoho stresu in vitro [Mytoprotective effect of thiol antioxidants in terms of modeling of nitrosating stress in vitro]. Zdobutky klinichnoi i eksperymentalnoi medytsyny, 2, 95–97. [in Ukrainian].
Pavlov, S. V., & Levchenko, K. V. (2016) Tsytoprotektyvni efekty skelektyvnykh moduliatoriv estrohenovykh retseptoriv za umov hipoksii kardiomiotsytiv in vitro [Cytoprotective effects of selective estrogen receptor modulators under hypoxia cardiomyocytes in vitro]. Farmakologiia ta likarska toksykologiia, 50(4–5), 78–83. [in Ukrainian].
Pavlov, S. V., & Bielenichev, I. F. (2013) Vmist stres bilka HSP70 i markeriv oksydatyvnoho stresu v holovnomu mozku schuriv na riznyh terminakh tserebralnoii ishemii [The content of HSP70 stress protein and markers of oxidative stress in the brain of rats at different stages of cerebral ischemia]. Odeskyi medychnyi zhurnal, 3, 10–13. [in Ukrainian].
Belenichev, I. F., Pavlov, S. V., & Sokolik, E. P. (2011) Disturbance of HSP70 Chaperone Activity is a Possible Mechanism of Mitochondrial Dysfunction. Neurochemical Journal, 5(4), 251–256. doi: 10.1134/S1819712411040040.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
